RSReinhard Schneppenheim

Reinhard Schneppenheim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Reinhard Schneppenheim has a total of 201 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Conformational Transition of Von Willebrand Factor’s D’D3 Domain Primes It For Multimerization

    by Sophia Gruber, Achim Löf, Adina Hausch, Res Jöhr, Tobias Obser, Gesa König, Reinhard Schneppenheim, Maria A. Brehm, Martin Benoit, Jan Lipfert

    Von Willebrand factor (VWF) is a multimeric plasma glycoprotein that is critically involved in hemostasis. Biosynthesis of long VWF concatemers in the endoplasmic reticulum and the (trans-)Golgi is still not fully understood. We use the single-molecule force spectroscopy technique magnetic tweezers to analyze a previously hypothesized conformational change in the D’D3 domain crucial for VWF multimerization. We find that the interface formed by submodules C8-3, TIL3, and E3 wrapping around VWD3 can open and expose two previously buried cysteines that are known to be vital for multimerization. By characterizing the conformational change at varying levels of force, we are able to quantify the kinetics of the transition and the stability of the interface. We find a pronounced destabilization of the interface upon lowering the pH from 7.4 to 6.2 and 5.5. This is consistent with initiation of the conformational change that enables VWF multimerization at the D’D3 domain by a decrease in pH in the trans-Golgi network and Weibel-Palade bodies. Furthermore, we find a stabilization of the interface in the presence of coagulation factor VIII (FVIII), providing evidence for a previously hypothesized binding site in submodule C8-3. Our findings highlight the critical role of the D’D3 domain in VWF biosynthesis and function and we anticipate our methodology to be applicable to study other, similar conformational changes in VWF and beyond.

  • Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study

    by Alberto Tosetto, Zahra Badiee, Mohammad‐Reza Baghaipour, Luciano Baronciani, Javier Battle, Erik Berntorp, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Jeroen C.J. Eikenboom, et al.


  • Alles fließt?

    by Rer. Nat Reinhard Schneppenheim, Maria Alexandra Brehm

    Zusammenfassung: Der von‐Willebrand‐Faktor ist ein zentrales Protein für die normale Hämostase mit unterschiedlichen strukturellen und funktionellen Domänen. Er bildet mit der Bindung an das exponierte Kollagen verletzter Gefäße und Thrombozyten mit deren Rezeptoren GPIb und GPIIb/IIIa die Matrix für den Ablauf der nachfolgenden Blutgerinnung. Quantitative und qualitative Defekte des VWF korrelieren mit dem von‐Willebrand‐Syndrom, der häufigsten Blutungsneigung, während das Fehlen der spezifischen VWF‐spaltenden Protease ADAMTS13 mit einer lebensbedrohlichen Mikroangiopathie assoziiert ist. Die Bedeutung des VWF für das Auftreten von Herzinfarkten und Schlaganfällen ist Gegenstand der aktuellen Forschung.

  • Open Access

    Von Willebrand Factor Mediates Pneumococcal Aggregation and Adhesion in Blood Flow

    by Hilger Jagau, Ina-Kristin Behrens, Karen Lahme, Georgina Lorz, Reinhard W. Köster, Reinhard Schneppenheim, Tobias Obser, Maria A. Brehm, Gesa König, Thomas P. Kohler, et al.

    Streptococcus pneumoniae is a major cause of community acquired pneumonia and septicaemia in humans. These diseases are frequently associated with thromboembolic cardiovascular complications. Pneumococci induce the exocytosis of endothelial Weibel-Palade Bodies and thereby actively stimulate the release of von Willebrand factor (VWF), which is an essential glycoprotein of the vascular haemostasis. Both, the pneumococcus induced pulmonary inflammation and the thromboembolytic complications are characterized by a dysbalanced haemostasis including a markedly increase in VWF plasma concentrations. Here, we describe for the first time VWF as a novel interaction partner of capsulated and non-encapsulated pneumococci. Moreover, cell culture infection analyses with primary endothelial cells characterized VWF as bridging molecule that mediates bacterial adherence to endothelial cells in a heparin-sensitive manner. Due to the mechanoresponsive changes of the VWF protein conformation and multimerization status, which occur in the blood stream, we used a microfluidic pump system to generate shear flow-induced multimeric VWF strings on endothelial cell surfaces and analysed attachment of RFP-expressing pneumococci in flow. By applying immuno fluorescence visualization and additional electron microscopy, we detected a frequent and enduring bacterial attachment to the VWF strings. Bacterial attachment to the endothelium was confirmed in vivo using a zebrafish infection model, which is described in many reports and acknowledged as suitable model to study haemostasis mechanisms and protein interactions of coagulation factors. Notably, we visualized the recruitment of zebrafish-derived VWF to the surface of pneumococci circulating in the blood stream and detected a VWF-dependent formation of bacterial aggregates within the vasculature of infected zebrafish larvae. Furthermore, we identified the surface-exposed bacterial enolase as pneumococcal VWF binding protein, which interacts with the VWF domain A1 and determined the binding kinetics by surface plasmon resonance. Subsequent epitope mapping using an enolase peptide array indicates that the peptide 195YGAEIFHALKKILKS210 might serve as a possible core sequence of the VWF interaction site. In conclusion, we describe a VWF-mediated mechanism for pneumococcal anchoring within the bloodstream via surface-displayed enolase, which promotes intravascular bacterial aggregation.


  • Open Access

    The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction

    by Reinhard Schneppenheim, Natalie Hellermann, Maria A. Brehm, Ulrike Klemm, Tobias Obser, Volker Huck, Stefan W. Schneider, Cécile V. Denis, Alexander Tischer, Matthew Auton, et al.

    The frequent von Willebrand factor (VWF) variant p.Phe2561Tyr is located within the C4 domain, which also harbors the platelet GPIIb/IIIa-binding RGD sequence. To investigate its potential effect on hemostasis, we genotyped 865 patients with coronary artery disease (CAD), 915 with myocardial infarction (MI), and 417 control patients (Ludwigshafen Risk and Cardiovascular Health Study) and performed functional studies of this variant. A univariate analysis of male and female carriers of the Tyr2561 allele aged 55 years or younger revealed an elevated risk for repeated MI (odds ratio, 2.53; 95% confidence interval [CI], 1.07-5.98). The odds ratio was even higher in females aged 55 years or younger, at a value of 5.93 (95% CI, 1.12-31.24). Cone and plate aggregometry showed that compared with Phe2561, Tyr2561 was associated with increased platelet aggregate size both in probands’ blood and with the recombinant variants. Microfluidic assays revealed that the critical shear rate for inducing aggregate formation was decreased to 50% by Tyr2561 compared with Phe2561. Differences in C-domain circular dichroism spectra resulting from Tyr2561 suggest an increased shear sensitivity of VWF as a result of altered association of the C domains that disrupts the normal dimer interface. In summary, our data emphasize the functional effect of the VWF C4 domain for VWF-mediated platelet aggregation in a shear-dependent manner and provide the first evidence that a functional variant of VWF plays a role in arterial thromboembolism.


  • ATRT-06. CLINICAL AND MOLECULAR RISK FACTORS IN CHILDREN WITH ATYPICAL TERATOID/RHABDOID TUMOUR (AT/RT) - EVIDENCE FROM THE EU-RHAB REGISTRY

    by Michael Fruehwald, Martin Hasselblatt, Reinhard Schneppenheim, Karolina Nemes, Susanne Bens, Pascal Johan, Peter Hauser, Eduardo Quiroga, Palma Solano-Paez, Veronica Biassoni, et al.

    AT/RT is a challenging entity due to a dearth of controlled clinical trials and lack of biological samples. We aimed to identify clinical and molecular risk factors in a carefully characterised series of AT/RT.

  • Koagulopathien

    by R. Schneppenheim, B. Zieger, C. Bidlingmaier, K. Kurnik, F. Bergmann

  • Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping

    by Alexander Tischer, Venkata R. Machha, Juan P. Frontroth, Maria A. Brehm, Tobias Obser, Reinhard Schneppenheim, Leland Mayne, S. Walter Englander, Matthew Auton


  • Mechano-Induced Unfolding of Von Willebrand Factor: A Clinical Example of Protein Destabilization

    by Camilo A. Aponte Santamaria, Svenja Lippok, Judith J. Mittag, Tobias Obser, Reinhard Schneppenheim, Carsten Baldauf, Frauke Gräter, Ulrich Budde, Joachim Rädler

  • Inherited Thrombotic Thrombocytopenic Purpura (Upshaw Schulman Syndrome) as Differential Diagnosis to Neonatal Septicaemia with Disseminated Intravascular Coagulation – a Case Series

    by Kai Lehmberg, Wolf A. Hassenpflug, Ilka Klaassen, Georg Hillebrand, Florian Oyen, Ulrich Budde, Dominique Singer, Reinhard Schneppenheim

    We report on 3 male neonates with hereditary ADAMTS13 deficiency (Upshaw Schulman syndrome, USS), the inherited form of thrombotic thrombocytopenic purpura (TTP). 2 presented shortly after birth with thrombocytopenia followed by microangiopathic Coombs-negative haemolytic anaemia. Both initially received antibiotic treatment for suspected infection-associated thrombocytopenia. In one patient’s brother, the first bout of incipient TTP did not occur before 6 months of age, despite the same genetic defect. ADAMTS13 activity was<5%, compound heterozygous mutations were found in all patients. USS constitutes a differential diagnosis to thrombocytopenia caused by disseminated intravascular coagulation in neonatal septicaemia. Administration of fresh frozen plasma usually resolves acute bouts of the disease. In some cases of thrombocytopenia of unknown origin in infancy, the resolution of signs and symptoms after infusion of plasma may point towards the diagnosis. Wir berichten über 3 männliche Neugeborene mit hereditärer ADAMTS13-Defizienz (Upshaw- Schulman Syndrom, USS), der hereditären Form der thrombotisch-thrombozytopenischen Purpura (TTP). 2 der Jungen wiesen kurz nach Geburt eine Thrombozytopenie auf, gefolgt von einer mikroangiopathischen Coombs-negativen hämolytischen Anämie. Unter dem Verdacht einer Infektions-assoziierten Thrombozytopenie erhielten initial beide eine antibiotische Therapie. Beim ebenfalls betroffenen jüngeren Bruder des einen Kindes traten die ersten Zeichen einer TTP-Episode erst mit 6 Monaten auf. Die Aktivität von ADAMTS13 betrug < 5% und compound heterozygote Mutationen wurden bei allen 3 Patienten gefunden. Das Upshaw-Schulman Syndrom stellt eine Differenzialdiagnose zur Thrombozytopenie im Rahmen einer disseminierten intravaskulären Gerinnung bei neonataler Sepsis dar. Die Verabreichung von fresh frozen plasma führt in der Regel zur zügigen Erholung der pathologischen Parameter. In Fällen von unklarer Thrombozytopenie im Säuglingsalter kann eine Besserung der Symptomatik nach Infusion von Plasma auf ein USS hinweisen.